Evidence map›Paper›PMID 34936123›Full record

ArticleMovement disorders : official journal of the Movement Disorder Society2022

The Myelin-Weighted Connectome in Parkinson's Disease.

Tommy Boshkovski, Julien Cohen-Adad, Bratislav Misic, Isabelle Arnulf, Jean-Christophe Corvol, Marie Vidailhet, Stéphane Lehéricy, Nikola Stikov, Matteo Mancini

Open access · hybridAbstract read
In one paragraph

Article in Movement disorders : official journal of the Movement Disorder Society, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.5field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Diagnostic Potential of Macromolecular Proton Fraction Mapping Combined with Quantitative Susceptibility Mapping as a Subcortical Biomarker for Parkinson's Disease.Magnetic resonance in medical sciences : MRMS : an official journal of Japan Society of Magnetic Resonance in Medicine · 2026
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Wrap it up: myelination of transplanted neurons for repair.Frontiers in cellular neuroscience · 2025
    Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 3 countries.

Tommy BoshkovskiNeuroPoly Lab, Polytechnique Montréal, Montréal, Quebec, Canada.ORCID 0000-0002-5243-5204
Julien Cohen-AdadNeuroPoly Lab, Polytechnique Montréal, Montréal, Quebec, Canada.
Bratislav MisicMontreal Neurological Institute, Montréal, Quebec, Canada.
Isabelle ArnulfSorbonne Université, Paris Brain Institute - ICM, INSERM, CNRS, Assistance Publique Hôpitaux de Paris, Hôpital Pitié-Salpêtrière, Paris, France.ORCID 0000-0002-2240-2516
Jean-Christophe CorvolSorbonne Université, Paris Brain Institute - ICM, INSERM, CNRS, Assistance Publique Hôpitaux de Paris, Hôpital Pitié-Salpêtrière, Paris, France.ORCID 0000-0001-7325-0199
Marie VidailhetSorbonne Université, Paris Brain Institute - ICM, INSERM, CNRS, Assistance Publique Hôpitaux de Paris, Hôpital Pitié-Salpêtrière, Paris, France.ORCID 0000-0002-2409-9143
Stéphane LehéricySorbonne Université, Paris Brain Institute - ICM, INSERM, CNRS, Assistance Publique Hôpitaux de Paris, Hôpital Pitié-Salpêtrière, Paris, France.
Nikola StikovNeuroPoly Lab, Polytechnique Montréal, Montréal, Quebec, Canada.
Matteo ManciniNeuroPoly Lab, Polytechnique Montréal, Montréal, Quebec, Canada.
Centre National de la Recherche Scientifique · FRBrighton and Sussex Medical School · GBInstitut Universitaire de Gériatrie de Montréal · CAMontreal Heart Institute · CAMontreal Neurological Institute and Hospital · CAPolytechnique Montréal · CA

Funding

ALTERNATIVE SPLICING OF THE AMYLOID PRECURSOR PROTEIN GENEZ01AG000501 · NIA · AGING · PI HIGGINS, G A · 1992 to 1992
–
Wellcome TrustWellcome Trust 213722/Z/18/Z
6 · The paper itself

Abstract

backgroundEven though Parkinson's disease (PD) is typically viewed as largely affecting gray matter, there is growing evidence that there are also structural changes in the white matter. Traditional connectomics methods that study PD may not be specific to underlying microstructural changes, such as myelin loss.

objectiveThe primary objective of this study is to investigate the PD-induced changes in myelin content in the connections emerging from the basal ganglia and the brainstem. For the weighting of the connectome, we used the longitudinal relaxation rate as a biologically grounded myelin-sensitive metric.

methodsWe computed the myelin-weighted connectome in 35 healthy control subjects and 81 patients with PD. We used partial least squares to highlight the differences between patients with PD and healthy control subjects. Then, a ring analysis was performed on selected brainstem and subcortical regions to evaluate each node's potential role as an epicenter for disease propagation. Then, we used behavioral partial least squares to relate the myelin alterations with clinical scores.

resultsMost connections (~80%) emerging from the basal ganglia showed a reduced myelin content. The connections emerging from potential epicentral nodes (substantia nigra, nucleus basalis of Meynert, amygdala, hippocampus, and midbrain) showed significant decrease in the longitudinal relaxation rate (P < 0.05). This effect was not seen for the medulla and the pons.

conclusionsThe myelin-weighted connectome was able to identify alteration of the myelin content in PD in basal ganglia connections. This could provide a different view on the importance of myelination in neurodegeneration and disease progression. © 2021 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

Indexed as

ConnectomeParkinson DiseaseWhite MatterHumansMagnetic Resonance ImagingMyelin SheathSubstantia NigraconnectomemyelinParkinson's disease

Identifiers

PMID34936123
PMCPMC9303520
OpenAlexW4200378875

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.